AtriCure, Inc. (A5I)
FSX
Real-time Data
06:00 AM
Day's Range
41.4052 wk Range
21.80Overview - A5I - AtriCure, Inc.
Key Statistics
Valuation
Enterprise Value
1.66B
P/E (Trailing)
‪223.33‬
P/E (Forward)
‪-63.91‬
PEG Ratio
‪-0.93‬
Price / Sales (TTM)
‪3.58‬
Price / Book
‪4.62‬
EV / EBITDA
‪57.82‬
Profitability
Gross Margin
‪77.23%‬
Profit Margin
‪1.85%‬
Operating Margin
‪6.29%‬
Return on Assets
‪1.25%‬
Return on Equity
‪2.15%‬
Ownership
Shares Outstanding
50.86M
Float
48.79M
Held by Insiders
‪3.80%‬
Held by Institutions
‪105.97%‬
Price stats
Beta
‪1.22‬
50-Day Avg
‪30.41‬
200-Day Avg
‪28.49‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - A5I - AtriCure, Inc.
Peers - A5I - AtriCure, Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on FSX.
Profile Summary - A5I - AtriCure, Inc.
About
AtriCure, Inc. is a leading innovator in surgical treatments for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management. The company develops and provides advanced medical technologies used by electrophysiologists, cardiothoracic surgeons, and thoracic surgeons worldwide…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
